We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-15.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$163B
AUM Growth
+$35.8B
Cap. Flow
+$63.1B
Cap. Flow %
38.57%
Top 10 Hldgs %
39.01%
Holding
5,544
New
561
Increased
1,332
Reduced
2,502
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 12.9%
2 Financials 7.33%
3 Healthcare 6.04%
4 Consumer Discretionary 5.46%
5 Communication Services 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GATO
5126
DELISTED
Gatos Silver, Inc.
GATO
$0 ﹤0.01%
10
-7,725
-100% -$27.1K
INAQU
5127
DELISTED
Insight Acquisition Corp. Units
INAQU
-10,000
Closed -$99K
LEV
5128
DELISTED
The Lion Electric Company
LEV
-158,100
Closed -$1.33M
ACABU
5129
DELISTED
Atlantic Coastal Acquisition Corp. II Unit
ACABU
-500,000
Closed -$4.99M
JWSM.WS
5130
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$0 ﹤0.01%
250
ITI
5131
DELISTED
Iteris, Inc.
ITI
-6,877
Closed -$20K
ENSV
5132
DELISTED
Enservco Corp.
ENSV
-19,708
Closed -$53K
SEEL
5133
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-4
Closed -$13K
GTHX
5134
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-224
Closed -$2K
SILK
5135
CALL
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-72,400
Closed -$2.99M
IRAA
5136
DELISTED
Iris Acquisition Corp Class A Common Stock
IRAA
-74,999
Closed -$733K
TLIS
5137
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
-229
Closed -$5K
ASXC
5138
DELISTED
Asensus Surgical, Inc.
ASXC
-37,983
Closed -$24K
CVII
5139
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
-25,000
Closed -$245K
PRST
5140
DELISTED
Presto Technologies, Inc. Common Stock
PRST
-353,815
Closed -$3.58M
ASTR
5141
PUT
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
-67
Closed -$4K
VCXB.U
5142
DELISTED
10X Capital Venture Acquisition Corp III Units
VCXB.U
-500,000
Closed -$5.01M
DMTK
5143
DELISTED
DermTech, Inc. Common Stock
DMTK
-4,022
Closed -$59K
TARO
5144
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$0 ﹤0.01%
2
CLVT.PRA
5145
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
-38,697
Closed -$2.63M
MRNS
5146
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-5,996
Closed -$56K
TAST
5147
DELISTED
Carrols Restaurant Group, Inc.
TAST
-5,430
Closed -$12K
TRVN
5148
DELISTED
Trevena, Inc.
TRVN
$0 ﹤0.01%
1
-41
-98% -$9.02K
SCRM
5149
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
-151,109
Closed -$1.47M
AFIB
5150
DELISTED
Acutus Medical Inc
AFIB
-3,104
Closed -$5K

Similar funds

Barclays's Q2 2022 Portfolio in Review

As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.

  • Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
  • Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
  • Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
  • Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
  • Barclays opened 561 new positions and closed 413 in Q2 2022.
  • Barclays's portfolio value rose 28% quarter-over-quarter to $163B.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.